DaVita HealthCare Partners (NYSE: DVA) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), DaVita HealthCare Partners beat slightly on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share grew significantly. GAAP earnings per share contracted significantly.

Margins shrank across the board.

Revenue details
 DaVita HealthCare Partners logged revenue of $2.83 billion. The 12 analysts polled by S&P Capital IQ predicted sales of $2.79 billion on the same basis. GAAP reported sales were 52% higher than the prior-year quarter's $1.86 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $1.84. The 15 earnings estimates compiled by S&P Capital IQ predicted $1.80 per share. Non-GAAP EPS of $1.84 for Q1 were 26% higher than the prior-year quarter's $1.46 per share. GAAP EPS of $0.28 for Q1 were 81% lower than the prior-year quarter's $1.46 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 30.9%, 140 basis points worse than the prior-year quarter. Operating margin was 5.6%, much worse than the prior-year quarter. Net margin was 1.1%, 640 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $2.86 billion. On the bottom line, the average EPS estimate is $1.81.

Next year's average estimate for revenue is $11.65 billion. The average EPS estimate is $7.46.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 325 members out of 337 rating the stock outperform, and 12 members rating it underperform. Among 94 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 92 give DaVita HealthCare Partners a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DaVita HealthCare Partners is outperform, with an average price target of $124.73.

Is DaVita HealthCare Partners the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.